Effects of Dopamine Agonists and Antagonists in Tourette's Disease

Archives of General Psychiatry

Volumn 36, Issue 9, 1979, Pages 979-985

  Feinberg, Michael ^a   Carroll, Bernard J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; APOMORPHINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; LEVAMFETAMINE SUCCINATE; PIRIBEDIL; PLACEBO; UNCLASSIFIED DRUG;

ADOLESCENT; CASE REPORT; DRUG THERAPY; ETIOLOGY; GILLES DE LA TOURETTE SYNDROME; LEVAMFETAMINE SUCCINATE; PATHOGENESIS; THERAPY;

ADOLESCENT; ADULT; AMPHETAMINE; APOMORPHINE; CASE REPORT; CHILD; CLINICAL TRIALS; DEXTROAMPHETAMINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMAN; HYPERKINESIS; MALE; MOTOR ACTIVITY; PIRIBEDIL; RECEPTORS, DOPAMINE; TOURETTE SYNDROME;

EID: 0018755376     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1979.01780090065007     Document Type: Article

References (48)

1. Gilles de la Tourette G: Etude sur une affection nerveuse caracterisee par de l'Incoordination motrice accompagnee d'Echolalie et de coprolalie. Arch Neurol Paris 9:19-42, 1885.
2. Gilles de la Tourette G: Etude sur une affection nerveuse caracterisee par de l'Incoordination motrice accompagnee d'Echolalie et de coprolalie. Arch Neurol Paris 9:158-200, 1885.
3. Dewulf A, vanBogaert L: Etudes anatomo-cliniques de syndromes hypercinetiques complexes: III. Une observation anatomoclinique de maladie des tics (Gilles de la Tourette). Monatsschr Psychiatr Neurol 104:53-61, 1941.
4. Balthasar K: Uber das anatomische Substrat der generalisierten Tic-Krankheit (maladie des tics, Gilles de la Tourette): Entwicklungshemmung des Corpus Striatum. Arch Psychiatr Z Neurol 195:531-549, 1957.
5. Eisenberg L, Asher E, Kanner L: A clinical study of Gilles de la Tourette's disease (Maladie des tics) in children. Am J Psychiatry 115:715-723, 1959.
6. Lucas AR, Kauffman PE, Morris EM: Gilles de la Tourette's disease: A clinical study of 15 cases. J Am Acad Child Psychiatry 6:700-722, 1967.
7. Shapiro AK, Shapiro E, Wayne H: Treatment of Tourette's syndrome with haloperidol: Review of 34 cases. Arch Gen Psychiatry 28:92-97, 1973.
8. Carlsson A, Lindquist M: Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20:140-144, 1963.
9. Snyder SH, Taylor KM, Coyle JT, et al: The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am J Psychiatry 127:117-125, 1970.
10. Klempel K: Gilles de la Tourette's syndrome induced by L-dopa. S Afr Med J 48:1379-1380, 1974.
11. Golden GS: Gilles de la Tourette's syndrome following methylphenidate administration. Dev Med Child Neurol 16:76-78, 1974.
12. Bernheimer H, Birkmayer W, Hornykiewicz O, et al: Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415-455, 1973.
13. Klawans HL: The pharmacology of tardive dyskinesias. Am J Psychiatry 130:82-86, 1973.
14. Meyerhoff JL, Snyder SH: Catecholamines in Gilles de la Tourette's disease: A clinical study with amphetamine isomers, in Barbeau A, Chase T, Paulson G (eds): Advances in Neurology. New York, Raven Press, 1973, vol 1, pp 123-134.
15. Coyle JT, Snyder SH: Catecholamine uptake by synaptosomes in the rat brain: Stereospecificity in different areas. J Pharmacol Exp Ther 170:221-231, 1969.
16. Taylor KM, Snyder SH: Differential effects of D-and L-amphetamine on behavior and on catecholamine disposition and norepinephrine containing neurons of rat brain. Brain Res 28:295-309, 1971.
17. Conners CK: A teacher rating scale for use in drug studies with children. Am J Psychiatry 126:884-888, 1969.
18. Winter CA, Flataker L: Studies on heptazone (6-morpholino-4,4-diphenyl-3-heptanone hydrochloride) in comparison with other analgesic drugs. J Pharmacol Exp Ther 98:305-317, 1950.
19. Tarsy D, Baldessarini RJ: Pharmacologically induced behavioural supersensitivity to apomorphine. Nature New Biol 245:262-263, 1973.
20. Fjalland B, Moller-Nielsen I: Enhancement of methylphenidateinduced stereotypies by repeated administration of neuroleptics. Psychopharmacologia 34:105-109, 1974.
21. Gianutsos G, Drawbaugh RB, Hynes MD, et al: Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol. Life Sci 14:887-898, 1974.
22. Woodward H, Goldsmith PL: Cumulative Sum Techniques: Mathematical and Statistical Techniques for Industry, monograph 3. Edinburgh, Oliver and Boyd, 1964.
23. Wohl H: The Cusum plot: Its utility in the analysis of clinical data. N Engl J Med 296:1044-1045, 1977.
24. Asper H, Baggiolini M, Burki HR, et al: Tolerance phenomena with neuroleptics: Catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and multiple administration of loxapine and haloperidol. Eur J Pharmacol 22:287-294, 1973.
25. Moller-Nielsen I, Fjalland B, Pederson V, et al: Pharmacology of neuroleptics upon repeated administration. Psychopharmacologia 34:95-104, 1974.
26. Ferris RM, Tang FLM, Maxwell RA: A comparison of the capacities of the isomers of amphetamine, deoxypipradol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of the rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. J Pharmacol Exp Ther 181:407-416, 1972.
27. Harris JE, Baldessarini RJ: Uptake of 3H-catecholamines by homogenates of rat corpus striatum and cerebral cortex: Effects of amphetamine analogues. Neuropharmacology 12:669-679, 1973.
28. Cohen DJ, Shaywitz BA, Caparulo B, et al: Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration. Arch Gen Psychiatry 35:245-250, 1978.
29. Anden N-E, Rubenson A, Fuxe K, et al: Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627-628, 1967.
30. Duby SE, Cotzias GC, Papasviliou PS, et al: Injected apomorphine and orally administered levodopa in Parkinsonism. Arch Neurol 27:474-480, 1972.
31. Ernst AM: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10:316-323, 1967.
32. Tolosa EA: Paradoxical suppression of chorea by apomorphine. JAMA 229:1579-1580, 1974.
33. Carroll BJ, Curtis GC, Kokmen E: Paradoxical response to dopamine agonists in tardive dyskinesia. Am J Psychiatry 134:785-789, 1977.
34. Smith RC, Tamminga CA, Haraszti J, et al: Effects of dopamine agonists in tardive dyskinesia. Am J Psychiatry 134:763-768, 1977.
35. Braham J, Sarova-Pinhas I: Apomorphine in dystonia musculorum deformans. Lancet 1:432-433, 1973.
36. Kehr W, Carlsson A, Lindquist M, et al: Evidence for a receptormediated feedback control of striatal tyrosine hydroxylase activity. J Pharm Pharmacol 24:744-747, 1972.
37. Aghajanian GK, Bunney BS: Pre-and postsynaptic feedback mechanisms in central dopaminergic neurons, in Seeman P, Brown BM (eds): Frontiers in Neurology and Neuroscience Research: First International Symposium of the Neuroscience Institute. Toronto, University of Toronto, 1974, pp 4-11.
38. Farnebo L-O, Hamberger B: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol Scand 37(suppl):35-44, 1971.
39. Carlsson A, Engel J, Strombom U, et al: Suppression by dopamineagonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn Schmiedebergs Arch Pharmacol 283:117-128, 1974.
40. Hornykiewicz O, Lisch H-J: On the course of the nigrostriatal dopamine neurons in the human brain: Studies in normal and Parkinson material, in Barbeau A, Brunette J-R (eds): Progress in Neuro-Genetics. Amsterdam, Excerpta Medica, 1967, vol 1, pp 255-257.
41. Goldstein M, Freedman LS, Backstrom T: The inhibition of catecholamine synthesis by apomorphine. J Pharm Pharmacol 22:715-717, 1970.
42. Gale K, Guidotti A, Costa E: Dopamine-sensitive adenylate cyclase: Location in substantia nigra. Science 195:503-505, 1977.
43. Barbeau A: Biology of the striatum, in Gaull G (ed): Biology of Brain Dysfunction. New York, Plenum Press Inc, 1973, pp 333-350.
44. Walters JR, Roth RH: Dopaminergic neurons: Drug-induced antagonism of the increase in tyrosine hydroxylase produced by cessation of impulse flow. J Pharmacol Exp Ther 191:82-91, 1974.
45. Post RM, Gerner RH, Carman JS, et al: Effects of low doses of a dopamine receptor stimulant in mania. Lancet 1:203-204, 1976.
46. Sweet RD, Bruun R, Shapiro E, et al: Presynaptic catecholamine antagonists as treatment for Tourette syndrome. Arch Gen Psychiatry 31:857-861, 1974.
47. Dafny N, Dauth G, Gilman S: Direct input from amygdaloid complex to caudate nucleus of the rat. Exp Brain Res 23:203-210, 1975.
48. Shapiro AK, Shapiro E, Wayne HL, et al: Tourette's syndrome: Summary of data on 34 patients. Psychosom Med 35:419-435, 1973.